Sonim Technologies INC Form 4 insider transactions

DNA X, Inc.'s Chief Financial Officer, Clayton Crolius, was granted 35,000 restricted stock units vesting over one year.

DNA X, Inc.'s Acting CEO, Michael C. Mulica, was granted 50,000 restricted stock units, increasing his beneficial ownership.

Following Sonim Technologies Inc.'s recent offering of 7.4 million shares, director Laurence W. Lytton's beneficial ownership has fallen below the 10% threshold, as reported in a recent SEC Form 4 filing.

Laurence W. Lytton, a Director and 10% Owner of Sonim Technologies Inc., reported the sale of 866,916 shares of common stock across two transactions in late June 2025.

Laurence W. Lytton reports ceasing to beneficially own more than 10% of Sonim Technologies Inc.'s outstanding common stock due to a change in the number of shares outstanding.

Charles Becher, Chief Commercial Officer and General Manager of North America at Sonim Technologies, sold shares to cover tax withholding obligations related to vesting restricted stock units.

Michael C. Mulica, a director of Sonim Technologies, sold shares to cover tax withholding obligations related to the vesting of restricted stock units.

Clayton Crolius, CFO of Sonim Technologies, sold 11,634 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Director James S. Cassano sold 23,381 shares of Sonim Technologies to cover tax withholding obligations related to vesting restricted stock units.

Director Jeffrey Wang sold 4,478 shares of Sonim Technologies to cover tax withholding obligations related to vesting restricted stock units.

Director Jack Steenstra sold shares of Sonim Technologies to cover tax withholding obligations related to vesting restricted stock units.

Director Michael Mulica reported the acquisition of restricted stock units and updated holdings in Sonim Technologies.

Director Jack Steenstra reports receiving a grant of restricted stock units and discloses holdings in Sonim Technologies.

Director James S. Cassano reports acquisition of restricted stock units and current holdings in Sonim Technologies.

Charles Becher, Chief Commercial Officer and General Manager of North America at Sonim Technologies, reports the acquisition of restricted stock units and current holdings of common stock and unvested restricted stock units.

Clayton Crolius, CFO of Sonim Technologies, reports the acquisition of restricted stock units and current holdings of common stock and unvested restricted stock units.

Sonim Technologies CEO Hao Peter Liu reports acquiring 63,604 shares of common stock through restricted stock units.

Director Michael Mulica of Sonim Technologies reported acquiring shares through restricted stock units and selling shares to cover tax obligations.

Director Jack Steenstra sold 1,623 shares of Sonim Technologies to cover tax withholding obligations related to vesting restricted stock units.

Director James S. Cassano sold 1,623 shares of Sonim Technologies to cover tax withholding obligations related to vesting restricted stock units.

Jeffrey Wang, a director at Sonim Technologies, sold 1,623 shares of common stock on July 19, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Director Michael Mulica reported the acquisition of restricted stock units and the sale of shares to cover tax obligations.

Director Jack Steenstra of Sonim Technologies reports acquisition of restricted stock units and subsequent sale of shares to cover tax obligations.

Director James S. Cassano reports acquisition and disposal of Sonim Technologies (SONM) stock, including the grant of restricted stock units and sales to cover tax obligations.

Director Jeffrey Wang reports acquisition and disposal of Sonim Technologies (SONM) stock due to restricted stock unit vesting and tax obligations.

Clayton Crolius, CFO of Sonim Technologies, acquired 170,000 employee stock options on April 8, 2024, exercisable starting April 8, 2025.